When was Olympic Ophthalmics founded?

Olympic Ophthalmics was founded in 2020.

Where is Olympic Ophthalmics located?

Olympic Ophthalmics is headquartered in Issaquah, United States.

How many employees does Olympic Ophthalmics have?

As of Jun 30, 2026, the latest employee count at Olympic Ophthalmics is 3.

Is Olympic Ophthalmics a funded company?

Olympic Ophthalmics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Olympic Ophthalmics rank among its competitors?

Olympic Ophthalmics ranks 15th amongst 40 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was 2EyesVision, which secured $100K in Mar, 2021.

Who are the top competitors of Olympic Ophthalmics?

Olympic Ophthalmics' top competitors include TearScience, Tear Film Innovations and Oculeve. Among them, 2EyesVision secured the most recent funding round in March, 2021.

Olympic Ophthalmics - 2026 Company Profile, Funding & Competitors

Company Details

Provider and developer of tear production device for treatments of dry eye disease. The company has developed iTEAR 100 a medical device technology that has the ability to stimulate tear production in an individual using neurostimulation methodology. It also has an app that can be used by doctors and patients to share medical documents, prescription data, and track health.

Website: olympicophthalmics.com
Email ID: *****@oo-med.com

Key Metrics

Founded Year

2020

Location

Issaquah, United States

Stage

Funding Raised

Investors

Saints Capital & 2 more

Ranked

15^th among 40 active competitors

Employee Count

3 as on Jun 30, 2026

Similar Companies

TearScience & 44 more

View Olympic Ophthalmics' full profile

Olympic Ophthalmics is a funded company. Olympic Ophthalmics has 3 institutional investors.

View details of Olympic Ophthalmics's funding rounds and investors

Olympic Ophthalmics' employee count trend

Olympic Ophthalmics has 3 employees as of Jun 26. Here is Olympic Ophthalmics's employee count trend over the years:

Employee count trend for Olympic Ophthalmics

Uncover Olympic Ophthalmics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Olympic Ophthalmics include TearScience, Tear Film Innovations and Oculeve. Here is the list of Top 10 competitors of Olympic Ophthalmics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TearScience 2005, Morrisville (United States), Acquired	Innovating eye health solutions for a lifetime of clear vision	$151M	eneralcatalyst.com, Quaker Partners Management ... & 7 others	43/100
2nd	Tear Film Innovations 2012, San Diego (United States), Acquired	Device to stimulate and produce tears from the meibomian glands to treat evaporative dry-eye	$17.7M	Visionary Ventures, Tigris Ventures & 2 others	41/100
3rd	Oculeve 2011, San Francisco (United States), Acquired	Device for dry eye disease	$24.9M	Versant Ventures, Kleiner Perkins & 3 others	41/100
4th	Bruder Healthcare 1986, Alpharetta (United States), Acquired	Products for dry eye and pain management	$5.17M	Fulcrum Equity Partners, Greybrook	40/100
5th	Myopia 2018, Aguilas (Spain), Funding Raised	Provider of an app for preventing myopia	-	Capital Certainty	39/100
6th	2EyesVision 2015, Madrid (Spain), Series A	Developer of portable technologies for multifocal correction before intraocular surgeries	$100K	Bullnet Capital, Luminate & 2 others	36/100
7th	Binovi 2011, Oakville (Canada), Public	Provides software-based solutions for vision therapy plan to optometry professionals and patients	-	-	32/100
8th	Neurapy 2018, Chennai (India), Unfunded	Provider of vision therapy software and tools for eye problems	-	-	31/100
9th	Sinopsys Surgical 2011, Boulder (United States), Deadpooled	Lacrimal stent and procedure to treat sinusitis	$9.57M	Mercury Fund, High Country Ventures & 3 others	30/100
10th	EyeGiene 2010, Danville (United States), Unfunded	Device for the treatment of dry eyes	-	-	30/100
15th	Olympic Ophthalmics 2020, Issaquah (United States), Funding Raised	Provider and developer of tear production device for treatments of dry eye disease	-	Saints Capital, BioStar Capital & 1 others	28/100